Ressources
Publications
STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway – Oncogene, Oct.8 2021

Publications
Paediatric Liver Cancer
A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy
Publications
Paediatric Liver Cancer
Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine
Publications
Paediatric Liver Cancer
A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma
publications
Paediatric Liver Cancer
Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine
publications
Paediatric Liver Cancer
A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma
publications
2D PDX-derived primary cultures
A new and fast in vitro screen to predict in vivo drug efficacy using cell primary culture from patient derived tumor established xenografts
publications
Liver Cancer
Myc Target miRs and Liver Cancer: Small Molecules to Get Myc Sick
01Conferences & events
04.14.23
XenTech will attend AACR Annual Meeting in Orlando (Apr. 14-19 2023)
Philippe, Olivier and Delphine cordially invite you to stop by our Booth#618 to discuss our solid tumor PDX collection to bring your innovative research projects a step further !
03.13.23
XenTech will attend the World ADC London (Mar.- 13-16th)
Philippe and Olivier cordially invite you to stop by our Booth#12 to discuss our long experience in testing ADCs in our solid tumor PDX collection !
01.24.23
XenTech will attend the DDR inhibitors Summit 2023 (Boston, Jan. 24-26)
Our Head of R&D Oliver Déas will be delighted to discuss with you as he'll be attending in person.


